跳至主要内容
临床试验/NCT03686059
NCT03686059已完成4 期

Outcome of Concomitant Use of Punctal Plugs and Omeg 3 Fatty Acids on Ocular Surface Disease in Patients Using Systemic Isotretinoin

Benha University1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2018年7月2日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
90
试验地点
1
主要终点
Change in Break up Time at baseline and during the study

研究概览

简要总结

Ocular surface disease is a common adverse effect of systemic isotretinoin therapy.

The investigators consider that punctal plugs and Omega 3 is a good line for treatment of ocular surface disease associated with systemic isotretinoin therapy

详细描述

Subjective and objective evaluation of ocular surface disease was done at baseline ,1 and 3 months of the study .

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • systemic isotretinoin therapy

排除标准

  • systemic or ocular diseases ,previous ocular surgery, corneal pathology and contact lens wearer

研究组 & 干预措施

punctal plug

Experimental

SOFT PLUG® Preloaded Silicone Plugs by OASIS®

干预措施: punctal plug (Device)

Combined

Experimental

SOFT PLUG® Preloaded Silicone Plugs by OASIS® plus Daily intake of DHA (docosahexaenoic acid)

干预措施: Omega 3 (Drug)

Combined

Experimental

SOFT PLUG® Preloaded Silicone Plugs by OASIS® plus Daily intake of DHA (docosahexaenoic acid)

干预措施: punctal plug (Device)

结局指标

主要结局

Change in Break up Time at baseline and during the study

时间窗: 3 months

fluorescein sodium stripes will be used for measurement of Break up Time in seconds

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Tarek Roshdy mohamed Mahgoub ELhamaky

lecturer of ophthalmology

Benha University

研究点 (1)

Loading locations...

相似试验